FTC Issues Policy Statement on Patent Listing | Dechert LLP
The FTC is focusing its attention on the listing of pharmaceutical patents in the FDA’s Orange Book. Patent listing may be the subject of FTC inquiry even absent...
Source: jdsupra.com
Stay updated with breaking news from Book Policy Statementat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FTC is focusing its attention on the listing of pharmaceutical patents in the FDA’s Orange Book. Patent listing may be the subject of FTC inquiry even absent...